BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27100877)

  • 1. A Balanced Tissue Composition Reveals New Metabolic and Gene Expression Markers in Prostate Cancer.
    Tessem MB; Bertilsson H; Angelsen A; Bathen TF; Drabløs F; Rye MB
    PLoS One; 2016; 11(4):e0153727. PubMed ID: 27100877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol synthesis pathway genes in prostate cancer are transcriptionally downregulated when tissue confounding is minimized.
    Rye MB; Bertilsson H; Andersen MK; Rise K; Bathen TF; Drabløs F; Tessem MB
    BMC Cancer; 2018 Apr; 18(1):478. PubMed ID: 29703166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative metabolic and transcriptomic profiling of prostate cancer tissue containing reactive stroma.
    Andersen MK; Rise K; Giskeødegård GF; Richardsen E; Bertilsson H; Størkersen Ø; Bathen TF; Rye M; Tessem MB
    Sci Rep; 2018 Sep; 8(1):14269. PubMed ID: 30250137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asporin is a stromally expressed marker associated with prostate cancer progression.
    Rochette A; Boufaied N; Scarlata E; Hamel L; Brimo F; Whitaker HC; Ramos-Montoya A; Neal DE; Dragomir A; Aprikian A; Chevalier S; Thomson AA
    Br J Cancer; 2017 Mar; 116(6):775-784. PubMed ID: 28152543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in gene transcription underlying the aberrant citrate and choline metabolism in human prostate cancer samples.
    Bertilsson H; Tessem MB; Flatberg A; Viset T; Gribbestad I; Angelsen A; Halgunset J
    Clin Cancer Res; 2012 Jun; 18(12):3261-9. PubMed ID: 22510345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of Metabolomics and Transcriptomics Reveals Major Metabolic Pathways and Potential Biomarker Involved in Prostate Cancer.
    Ren S; Shao Y; Zhao X; Hong CS; Wang F; Lu X; Li J; Ye G; Yan M; Zhuang Z; Xu C; Xu G; Sun Y
    Mol Cell Proteomics; 2016 Jan; 15(1):154-63. PubMed ID: 26545398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate tumors downregulate microseminoprotein-beta (MSMB) in the surrounding benign prostate epithelium and this response is associated with tumor aggressiveness.
    Bergström SH; Järemo H; Nilsson M; Adamo HH; Bergh A
    Prostate; 2018 Mar; 78(4):257-265. PubMed ID: 29250809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of malic enzymes leads to metabolic imbalance and altered levels of trehalose and putrescine in the bacterium Sinorhizobium meliloti.
    Zhang Y; Smallbone LA; diCenzo GC; Morton R; Finan TM
    BMC Microbiol; 2016 Jul; 16(1):163. PubMed ID: 27456220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OXPHOS remodeling in high-grade prostate cancer involves mtDNA mutations and increased succinate oxidation.
    Schöpf B; Weissensteiner H; Schäfer G; Fazzini F; Charoentong P; Naschberger A; Rupp B; Fendt L; Bukur V; Giese I; Sorn P; Sant'Anna-Silva AC; Iglesias-Gonzalez J; Sahin U; Kronenberg F; Gnaiger E; Klocker H
    Nat Commun; 2020 Mar; 11(1):1487. PubMed ID: 32198407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies.
    Alinezhad S; Väänänen RM; Mattsson J; Li Y; Tallgrén T; Tong Ochoa N; Bjartell A; Åkerfelt M; Taimen P; Boström PJ; Pettersson K; Nees M
    PLoS One; 2016; 11(5):e0155901. PubMed ID: 27196083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell type specific gene expression analysis of prostate needle biopsies resolves tumor tissue heterogeneity.
    Krönig M; Walter M; Drendel V; Werner M; Jilg CA; Richter AS; Backofen R; McGarry D; Follo M; Schultze-Seemann W; Schüle R
    Oncotarget; 2015 Jan; 6(2):1302-14. PubMed ID: 25514598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Citrate transport and metabolism in mammalian cells: prostate epithelial cells and prostate cancer.
    Mycielska ME; Patel A; Rizaner N; Mazurek MP; Keun H; Patel A; Ganapathy V; Djamgoz MB
    Bioessays; 2009 Jan; 31(1):10-20. PubMed ID: 19153992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of tissue metabolomics, transcriptomics and immunohistochemistry reveals ERG- and gleason score-specific metabolomic alterations in prostate cancer.
    Meller S; Meyer HA; Bethan B; Dietrich D; Maldonado SG; Lein M; Montani M; Reszka R; Schatz P; Peter E; Stephan C; Jung K; Kamlage B; Kristiansen G
    Oncotarget; 2016 Jan; 7(2):1421-38. PubMed ID: 26623558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologically targetable vulnerability in prostate cancer carrying RB1-SUCLA2 deletion.
    Kohno S; Linn P; Nagatani N; Watanabe Y; Kumar S; Soga T; Takahashi C
    Oncogene; 2020 Aug; 39(34):5690-5707. PubMed ID: 32694611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of Histopathologic Tissue Composition to Quantitative MR Spectroscopy and Diffusion-weighted Imaging of the Prostate.
    Kobus T; van der Laak JA; Maas MC; Hambrock T; Bruggink CC; Hulsbergen-van de Kaa CA; Scheenen TW; Heerschap A
    Radiology; 2016 Mar; 278(3):801-11. PubMed ID: 26418614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots.
    Costello LC; Franklin RB
    Mol Cancer; 2006 May; 5():17. PubMed ID: 16700911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MPC1, a key gene in cancer metabolism, is regulated by COUPTFII in human prostate cancer.
    Wang L; Xu M; Qin J; Lin SC; Lee HJ; Tsai SY; Tsai MJ
    Oncotarget; 2016 Mar; 7(12):14673-83. PubMed ID: 26895100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of PDGFR-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence.
    Nordby Y; Richardsen E; Rakaee M; Ness N; Donnem T; Patel HR; Busund LT; Bremnes RM; Andersen S
    Sci Rep; 2017 Feb; 7():43378. PubMed ID: 28233816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. hZIP1 zinc uptake transporter down regulation and zinc depletion in prostate cancer.
    Franklin RB; Feng P; Milon B; Desouki MM; Singh KK; Kajdacsy-Balla A; Bagasra O; Costello LC
    Mol Cancer; 2005 Sep; 4():32. PubMed ID: 16153295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of ribosomal proteins in normal and cancerous human prostate tissue.
    Arthurs C; Murtaza BN; Thomson C; Dickens K; Henrique R; Patel HRH; Beltran M; Millar M; Thrasivoulou C; Ahmed A
    PLoS One; 2017; 12(10):e0186047. PubMed ID: 29016636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.